Geratherm Medical AG (LON: 0EL9)

Geratherm Medical AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	18.31	21.6	26.42	24.41	28.12	20.33
Other Revenue	-	-	-	0.12	0.11	0.13
Revenue	18.31	21.6	26.42	24.53	28.24	20.46
Revenue Growth (YoY)	-28.71%	-18.24%	7.67%	-13.11%	38.01%	-6.69%
Cost of Revenue	4.91	5.11	10.12	8.79	10.53	6.65
Gross Profit	13.39	16.49	16.29	15.74	17.71	13.81
Selling, General & Admin	8.12	8.5	8.43	8.83	8.5	7.57
Other Operating Expenses	3.67	4.05	4.12	4.68	4.39	3.93
Operating Expenses	13.69	14.27	14.03	15.25	14.23	12.83
Operating Income	-0.29	2.22	2.26	0.49	3.49	0.98
Interest Expense	-0.16	-0.15	-0.18	-0.14	-0.27	-0.23
Interest & Investment Income	0.12	0.09	0.01	0.03	0	0
Earnings From Equity Investments	-	-	-	-0.03	-0.05	-
Currency Exchange Gain (Loss)	-0.11	-0.11	0.19	0.1	-0.52	-0.03
Other Non Operating Income (Expenses)	0.28	0.56	0.05	0.03	0.04	0.27
EBT Excluding Unusual Items	-0.17	2.6	2.33	0.47	2.69	1
Merger & Restructuring Charges	-	-	-	-0	-	-
Gain (Loss) on Sale of Investments	-0.69	-0.53	-0.75	-0.21	-0	-0
Other Unusual Items	0.22	0.22	0.11	0.03	0.02	0.04
Pretax Income	-0.62	2.31	1.71	0.31	2.72	1.04
Income Tax Expense	0.4	0.65	0.63	-0.03	0.82	0.75
Earnings From Continuing Operations	-1.01	1.67	1.08	0.33	1.9	0.29
Minority Interest in Earnings	0.18	-0.55	-0.06	-0.21	0.14	0.26
Net Income	-0.83	1.11	1.02	0.12	2.05	0.55
Net Income to Common	-0.83	1.11	1.02	0.12	2.05	0.55
Net Income Growth	-	8.57%	737.28%	-94.02%	274.88%	-41.26%
Shares Outstanding (Basic)	5	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5	5
Shares Change (YoY)	-0.89%	-0.61%	10.00%	-	-	-
EPS (Basic)	-0.15	0.21	0.19	0.02	0.41	0.11
EPS (Diluted)	-0.15	0.21	0.19	0.02	0.41	0.11
EPS Growth	-	9.23%	839.80%	-95.12%	272.73%	-41.38%
Free Cash Flow	-0.7	0.71	0.64	0.18	2.05	-0.78
Free Cash Flow Per Share	-0.13	0.13	0.12	0.04	0.41	-0.16
Dividend Per Share	0.100	0.100	0.150	0.120	0.400	0.250
Dividend Growth	-33.33%	-33.33%	25.00%	-70.00%	60.00%	-37.50%
Gross Margin	73.16%	76.36%	61.68%	64.16%	62.72%	67.49%
Operating Margin	-1.60%	10.27%	8.56%	1.98%	12.34%	4.80%
Profit Margin	-4.54%	5.14%	3.87%	0.50%	7.24%	2.67%
Free Cash Flow Margin	-3.80%	3.31%	2.43%	0.73%	7.24%	-3.83%
EBITDA	1.61	3.94	3.74	1.79	4.42	1.9
EBITDA Margin	8.77%	18.24%	14.15%	7.32%	15.65%	9.30%
D&A For EBITDA	1.9	1.72	1.48	1.31	0.93	0.92
EBIT	-0.29	2.22	2.26	0.49	3.49	0.98
EBIT Margin	-1.60%	10.27%	8.56%	1.98%	12.34%	4.80%
Effective Tax Rate	-	27.93%	36.82%	-	30.00%	72.07%
Revenue as Reported	20.93	25.74	27.74	25.87	27.7	21.74

Source: S&P Capital IQ. Standard template. Financial Sources.